Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

ADIL
Adial Pharmaceuticals, Inc
stock NASDAQ

At Close
Jul 28, 2026 3:59:53 PM EDT
2.95USD+4.982%(+0.14)62,988
2.87Bid   2.95Ask   0.08Spread
Pre-market
0.00USD-100.000%(-2.78)0
After-hours
Jul 28, 2026 4:54:30 PM EDT
2.87USD-2.712%(-0.08)100
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 24, 2022
09:27AM EST  Adial Pharmaceuticals Receives Notice Of Allowance On U.S. Patent For Treatment For Opioid Use Disorder Using AD04   Benzinga
09:25AM EST  Adial Pharmaceuticals Receives Notice of Allowance on U.S. Patent   GlobeNewswire Inc
Jan 10, 2022
09:04AM EST  Adial Pharmaceuticals to Present at the H.C. Wainwright BioConnect   GlobeNewswire Inc
Dec 22, 2021
09:25AM EST  Adial Pharmaceuticals Completes Private Placement of Common Stock   GlobeNewswire Inc
Dec 8, 2021
09:26AM EST  Adial Pharmaceuticals Appoints Cary J. Claiborne As COO   Benzinga
09:25AM EST  Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced the appointment of Cary J. Claiborne as Chief Operating Officer. Mr. Claiborne will continue to serve on the Board of Directors.   GlobeNewswire Inc
Nov 29, 2021
09:05AM EST  Adial Pharmaceuticals Announces Pre-Clinical Data For PNV2 As A Drug Candidate For Triple Negative Breast Cancer   Benzinga
09:00AM EST  Adial Pharmaceuticals Announces Positive Pre-Clinical Data for   GlobeNewswire Inc
Nov 17, 2021
09:43AM EST  REMINDER: Adial Pharmaceuticals to Host Conference Call Thursday,   GlobeNewswire Inc
Nov 10, 2021
09:26AM EST  Adial Pharmaceuticals Announces Private Placement of Common Stock   GlobeNewswire Inc
Nov 9, 2021
09:15AM EST  Adial Pharmaceuticals Schedules Conference Call to Provide   GlobeNewswire Inc
Nov 3, 2021
09:10AM EDT  Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced the appointment of Cary J. Claiborne to the Board of Directors, increasing the number of board members to seven.   GlobeNewswire Inc
Oct 21, 2021
12:12PM EDT  UPDATE: Adial Says In Recent Study 'PNV-5030 alone exhibited a significant pain reduction as compared to the control group and a similar effect to 1mg/kg morphine.'   Benzinga
10:14AM EDT  Results suggest potential of PNV-5030 as both a standalone and combination therapyto reduce or eliminate opioid use and achieve meaningful pain reduction   GlobeNewswire Inc
Oct 18, 2021
09:31AM EDT  Adial Pharmaceuticals To Present At Dawson James Securities 6th Annual Small Cap Growth Conference On October 21, 2021   Benzinga
09:30AM EDT  Adial Pharmaceuticals to Present at Dawson James Securities 6th   GlobeNewswire Inc
Oct 13, 2021
01:38PM EDT  Brookline Capital Initiates Coverage On Adial Pharmaceuticals with Buy Rating, Announces Price Target of $12   Benzinga
01:38PM EDT  Watching Shares Of Adial Pharmaceutical; Hearing Brookline Capital Initiates With Buy Rating, $12 Price Target   Benzinga
Oct 7, 2021
09:05AM EDT  Avalon GloboCare's Advanced Filtration Tech Could Help Stop Life-Threatening Cytokine Storm in COVID-19 Patients   Benzinga
Sep 30, 2021
09:26AM EDT  Adial Pharmaceuticals Announces Greater Than 50% Of Patients Expected To Complete ONWARD Phase 3 Trial Of AD04 For Treatment Of Alcohol Use Disorder Have Completed Full 24-Week Treatment Period; Says Trial Completion Anticipated Q1 2022   Benzinga
09:25AM EDT  Adial Pharmaceuticals Announces Greater Than 50% of Patients   GlobeNewswire Inc
Sep 28, 2021
09:49AM EDT  Adial Pharmaceuticals Announces Research Collaboration Agreement   GlobeNewswire Inc
Sep 15, 2021
10:08AM EDT  Adial CEO William Stilley Invited to Participate in Maxim   GlobeNewswire Inc
Sep 13, 2021
09:30AM EDT  Sysorex (OTCQB: SYSX) (Sysorex or the Company), the preeminent, U.S.-based, publicly traded Ethereum mining and technologies company, today announced that it has elected William B. Stilley, III to the Companys Board of Directors and as Chair of the Boards Audit Committee. The Company also expanded the size of its Board to five directors and established its Audit Committee.   GlobeNewswire Inc
Sep 8, 2021
07:32AM EDT  The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod   Benzinga
Sep 7, 2021
09:00AM EDT  Adial Pharmaceuticals to Present at the H.C. Wainwright 23rd   GlobeNewswire Inc
Aug 31, 2021
09:32AM EDT  Adial Pharmaceuticals Says Exceeds Enrollment Target In ONWARD Phase 3 Trial Of AD04 For Treatment of Patients With Alcohol Use Disorder   Benzinga
09:30AM EDT  Adial Pharmaceuticals Exceeds Enrollment Target in   GlobeNewswire Inc
Aug 20, 2021
10:48AM EDT  Adial Pharmaceuticals Reaches Full Enrollment Target For ONWARD Phase 3 Trial Of AD04 For Treatment Of Patients With Alcohol Use Disorder   Benzinga
10:45AM EDT  Adial Pharmaceuticals Reaches Full Enrollment Target for   GlobeNewswire Inc
09:41AM EDT  Adial Pharmaceuticals Shares Spike Higher; Co To Host Conference Call Today At 11 a.m. EDT To Provide Clinical Update, Discuss Business Developments   Benzinga
09:40AM EDT  Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (Adial or the Company), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, will host a conference call at 11:00 A.M. Eastern Time today, August 20, 2021 to provide a clinical update and discuss the latest business developments.   GlobeNewswire Inc
Aug 17, 2021
10:21AM EDT  Adial Pharmaceuticals CMO To Appear On Fox Business At 12:15 p.m.   Benzinga
Aug 12, 2021
02:50PM EDT  Adial Pharmaceuticals Schedules Conference Call to Provide   GlobeNewswire Inc
Aug 10, 2021
09:30AM EDT  Adial Pharmaceuticals Awarded U.S. And International Patents For Treatment Of Alcohol And Opioid Use Disorders Using AD04   Benzinga
09:30AM EDT  Adial Pharmaceuticals Awarded U.S. and International Patents for   GlobeNewswire Inc
Jul 14, 2021
02:01PM EDT  Adial Highlights Pre-Clinical Data For Its Adenosine Pain Platform   Benzinga
02:01PM EDT  Adial Announces Positive Pre-Clinical Data for its Adenosine Pain Platform   Benzinga
02:00PM EDT  Data merits further testing for pain reduction as a possible alternative to opioids   GlobeNewswire Inc
Jul 7, 2021
10:12AM EDT  Adial Announces $5,000,000Above Market Private   GlobeNewswire Inc
Jul 6, 2021
09:27AM EDT  Adial Pharmaceuticals Says Phase 3 ONWARD Trial Meets Screening Target, Nears Enrollment Completion   Benzinga
09:25AM EDT  The Phase 3 ONWARD Trial Meets its Screening   GlobeNewswire Inc
08:30AM EDT  Former member of the National Advisory Council on Drug Abuse   GlobeNewswire Inc
Jun 29, 2021
10:49AM EDT  Litchfield Hills Initiates Coverage On Adial Pharmaceuticals with Buy Rating, Announces Price Target of $5   Benzinga
Jun 28, 2021
11:25AM EDT  Shares of Adial Pharmaceuticals, Inc. (ADIL) are gaining over 12% on Monday morning after the clinical-stage biopharmaceutical company announced it has been added to the Russell Microcap Index.   RTTNews
09:45AM EDT  Adial Joins Russell Microcap Index   GlobeNewswire Inc
Jun 25, 2021
09:02AM EDT  FDA Denies Adial Pharma's Fast Track Request For AD04 in Alcohol Use Disorder   Benzinga
07:32AM EDT  The Daily Biotech Pulse: Roche Gets Authorization For COVID-19 Treatment, Nods For Sanofi-Regeneron In Europe, Osmotica Divestment, 2 IPOs   Benzinga
Jun 24, 2021
05:12PM EDT  Adial Pharmaceuticals Provides Regulatory And Development Update; Says Has Announced It Received Correspondence Related To Request For Fast Track Designation From FDA; Says Request Was Denied By FDA   Benzinga
05:08PM EDT  Adial Pharmaceuticals Provides Regulatory and Development Update   GlobeNewswire Inc
04:56AM EDT  The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 4.55 A.M.)   RTTNews
Jun 23, 2021
04:44AM EDT  44 Biggest Movers From Yesterday   Benzinga
Jun 22, 2021
10:36AM EDT  Adial Pharma Up 16% On Plan To Enter Genetic Testing Market   RTTNews
10:14AM EDT  Mid-Morning Market Update: Markets Mostly Lower; Korn Ferry Tops Q4 Estimates   Benzinga
09:56AM EDT  Adial Pharmaceuticals Plans to Enter Genetic Testing Market   GlobeNewswire Inc
Jun 21, 2021
04:04PM EDT  Adial Pharma. Shares Spike As Traders Circulate Article Titled 'Revisiting Adial Pharmaceuticals: EMA Approval For Alcohol Use Disorder Pill Is A Critical Catalyst'   Benzinga
Jun 7, 2021
09:30AM EDT  Adial Pharmaceuticals Comments on Article in The   GlobeNewswire Inc
Jun 3, 2021
09:55AM EDT  Adial Announces Funding of Management-Led $2,100,000 Above Market   GlobeNewswire Inc
May 18, 2021
01:19PM EDT  Adial Pharmaceuticals Featured on Multiple News Broadcasts   GlobeNewswire Inc
Apr 20, 2021
06:05AM EDT  Adial Pharmaceuticals Filed for Resale of Up to 700,001 Shares of Co's Common Stock, by Selling Stockholders   Benzinga
Mar 25, 2021
02:45PM EDT  Highlights From Day 1 Of Benzinga's Biotech Small Cap Conference   Benzinga
Mar 23, 2021
07:12PM EDT  Benzinga's Biotech Small Cap Conference Schedule For Wednesday, Mar. 24, 2021   Benzinga
Mar 17, 2021
10:00AM EDT  Adial Founder and Chief Medical Officer Dr. Bankole   GlobeNewswire Inc
Mar 15, 2021
09:32AM EDT  Adial Pharmaceuticals Says Entered Into Securities Purchase Agreements With Each Of Bespoke Growth Partners, 3 Entities Controlled By James Newman Jr And Keystone Capital Partners; Agrees To Sale Of Shares Totaling 700,001 Shares Of Common Stock At $3/Sha   Benzinga
09:30AM EDT  Adial Announces Management-Led $2,100,000Above Market   GlobeNewswire Inc
Feb 26, 2021
03:06PM EST  Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (Adial), a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today announced that it will host a Town Hall at 1 P.M., Eastern Time on Thursday, March 18, 2021.   GlobeNewswire Inc
11:20AM EST  Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (Adial or the Company), a clinical-stage biopharmaceutical company focused on the development of treatments for addictions, today announced the exercise of 712,500 warrants from its June 2020 financing for net proceeds to the company of $1,425,000.   GlobeNewswire Inc
Feb 25, 2021
09:34AM EST  Adial Pharmaceuticals Achieves 50% Enrollment in ONWARD Phase 3 Trial   Benzinga
09:30AM EST  Adial Pharmaceuticals Achieves 50% Enrollment in   GlobeNewswire Inc
Feb 23, 2021
01:01PM EST  Adial Says To File Fast Track Application For AD04 With FDA   Benzinga
01:00PM EST  Adial to File Fast Track Application for AD04 with the FDA   GlobeNewswire Inc
Feb 8, 2021
01:26PM EST  William B. Stilley, III Reports In 13D Filing An 11.1% Stake In Adial Pharmaceuticals   Benzinga
Dec 17, 2020
09:49AM EST  Adial Pharmaceuticals Reports Co Reaches 35% Enrollment In ONWARD Pivotal Phase 3 Trial Of AD04 For Treatment Of Alcohol Use Disorder; Says Trial On Track To Be Fully Enrolled During Q2 2021   Benzinga
Dec 10, 2020
09:36AM EST  Adial Pharmaceuticals Enters Agreement To Acquire Purnovate; Terms Not Disclosed   Benzinga
Dec 4, 2020
09:35AM EST  Adial Pharmaceuticals Shares See Volume; Co Releases PR Saying Lead Drug Candidate AD04 For Treatment of Alcohol Use Disorder Featured In Follow-up TV News Story   Benzinga
09:34AM EST  Adial Pharma S-1 Shows Registration For ~2.8M Share Common Stock Offering Via Selling Shareholders   Benzinga
Nov 3, 2020
09:52AM EST  Adial Pharmaceuticals Provides Update On Its ONWARD Pivotal Phase 3 Trial Of AD04 For Treatment Of Alcohol Use Disorder; Projected To be Fully Enrolled During Q2 2021   Benzinga
Oct 22, 2020
10:37AM EDT  Why Adial's Stock Is Trading Higher Today   Benzinga
09:30AM EDT  Todos Medical Announces Distribution Agreement with Adial   GlobeNewswire Inc
08:38AM EDT  Avalon GloboCare And Adial Pharmaceuticals Announce A Strategic Collaboration For The Global Distribution Of Coronavirus Point Of Care Antibody Rapid Test Devices   Benzinga
08:33AM EDT  UPDATE: Under agreement, Adial Grants Avalon Non-Exclusive, Sub-Distribution Rights Worldwide For The FaStep COVID-19 IgG/IgM Rapid Test Device And The Assure/EcoStep COVID-19 IgG/IgM Rapid Test Device, POC COVID-19 Antibody Tests   Benzinga
08:31AM EDT  Avalon GloboCare And Adial Pharmaceuticals Announce Collaboration For Global Distribution of COVID-19 Point-Of-Care Antibody Rapid Test Devices   Benzinga
08:30AM EDT  Avalon GloboCare and Adial Pharmaceuticals Announce Strategic   GlobeNewswire Inc
Oct 21, 2020
09:34AM EDT  Adial Pharma Reports FDA Reactivation Of Investigational New Drug Application For AD04 In Alcohol Use Disorder   Benzinga
Sep 30, 2020
10:11AM EDT  Mid-Morning Market Update: Markets Open Higher; Micron Issues Weak Earnings Forecast   Benzinga
09:26AM EDT  Adial Pharmaceuticals Announces Sale Of 10K Coronavirus Antibody Rapid test Devices   Benzinga
Sep 29, 2020
02:34PM EDT  Why Adial Pharmaceuticals Is Trading Higher Today   Benzinga
10:51AM EDT  Shares of nano-cap company Adial Pharmaceuticals, Inc. (ADIL) surged nearly 40% on Tuesday morning after FDA granted emergency use authorization for the company's COVID-19 point-of-care antibody test.   RTTNews
Sep 25, 2020
10:01AM EDT  Adial Pharmaceuticals Files For Expedited Review Of AD04 With FDA   Benzinga
Sep 22, 2020
09:32AM EDT  Adial Pharmaceuticals, iRemedy Partner To Sell Coronavirus Antibody Test Kits To U.S. Medical Providers, Commence Sales   Benzinga
Sep 18, 2020
09:40AM EDT  Adial Pharma 8-K Shows Co. Filed Its Investigational New Drug Application For Use Of Lead Product Candidate, AD04, As Treatment For Alcohol Use Disorder Off Inactive Status   Benzinga
Jul 28, 2020
09:35AM EDT  Adial Pharmaceuticals To Provide Update Regarding ONWARD Phase 3 Trial On Thursday, July 30   Benzinga
Jul 22, 2020
09:47AM EDT  Adial Pharmaceuticals Receives European Medicines Agency Agreement On The Pediatric Investigation Plan For AD04 In Alcohol Use Disorder   Benzinga
Jul 21, 2020
09:13AM EDT  Adial Pharmaceuticals On July 17 Received Notice That EMA Has Accepted PIP Submitted By Co. For Development Of Co.'s Lead Drug Candidate AD04   Benzinga
Jul 13, 2020
04:51PM EDT  Adial Pharmaceuticals Files Prospectus Related To Resale Of Up To 2.1M Shares Of Common Stock By Selling Stockholder   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC